Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydrocortisone + vitamin C + thiamine for severe sepsis or septic shock
IRCT20220219054058N1Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of hydrocortisone, ascorbic acid and thiamine in septic shock and sepsis (2 arms), sponsored by Arak University of Medical Sciences. Primary endpoints: Duration of intubation, Length of stay in intensive care unit and 7 more. Started Mar 2022; status: completed.
02
Drugs
hydrocortisoneascorbic acidthiamine
03
Conditions
septic shocksepsis
Beyond the preview
Go deeper on IRCT20220219054058N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220219054058N1.